Rezolute, Inc. Rezolute, Inc.
  • About Us
    • Mission
    • Leadership
    • Contact
  • Our Focus
    • Hyperinsulinism Therapeutics
    • Publications & Presentations
  • Our Pipeline
    • Development Pipeline
    • Ersodetug
    • Clinical Trials
    • Investigator Initiated Studies
  • Join Us
    • Our Culture
    • Job Openings
  • Investors & Media
    • Investors Overview
    • Corporate Presentation
    • Press Releases
    • Events
    • Stock Quote & Chart
    • Historical Data
    • Analyst Coverage
    • SEC Filings
    • Governance
    • Investor Contacts
  • for patients
    • Understanding Hyperinsulinism
    • Join the Rezolution
Select Page
Publications & Presentations

Our innovative development programs are backed by sound scientific research.

Filter by

XOMA 358, a Novel Treatment for Hyperinsulinemic Hypoglycemia: Safety and Clinical Pharmacology from the First in Human Trial

Rajneesh Nath et al.

ENDO

2015
Inhibition of insulin receptor function by a human, allosteric monoclonal antibody: A potential new approach for the treatment of hyperinsulinemic hypoglycemia

John A Corbin et al.

mAbs

01/2014
123
Footer logo

Join our passionate and dedicated team to make a difference for patients.

SEE OPEN JOBS
  • About Us
    • Mission
    • Leadership
    • Contact
  • Our Focus
    • Hyperinsulinism Therapeutics
    • Publications & Presentations
  • Our Pipeline
    • Development Pipeline
    • Ersodetug
    • Clinical Trials
    • Investigator Initiated Studies
  • Join Us
    • Our Culture
    • Job Openings
  • Investors & Media
    • Investors Overview
    • Corporate Presentation
    • Press Releases
    • Events
    • Stock Quote & Chart
    • Historical Data
    • Analyst Coverage
    • SEC Filings
    • Governance
    • Investor Contacts
  • for patients
    • Understanding Hyperinsulinism
    • Join the Rezolution
©2026 Rezolute, Inc. All rights reserved.  Privacy Policy   Terms of Use
Made by 22 Fillmore

Learn more about our development program for ersodetug as a treatment for all forms of hyperinsulinism.

Get Details